A Spatial-Temporal Approach to Surveillance of Prostate Cancer Disparities in Population Subgroups by Hsu, Chiehwen Ed et al.
BACKGROUND
Prostate cancer is among the most often diagnosedcancers in the United States, as it constitutes thesecond leading cause of cancer deaths among U.S.
men.1 More than 41,000 Americans died of prostate can-
cer in 2004.2 Statistical studies have identified the
racial/ethnic disparities of prostate cancer mortality
across regions and over time. U.S. African-American
males rank first and white men eighth in worldwide
prostate cancer mortality rates.3 National data indicate
that prostate cancer mortality rates decreased during the
1990s, while the decreases were almost twice as great for
whites and Asians/Pacific Islanders than for African
Americans, American Indians/Alaska Natives and His-
panics.4 Despite the evident general decline in prostate
cancer mortality rates among all racial/ethnic groups
during the ’90s (possibly due to the wide adoption of
prostate-specific antigen testing),5 it is unclear whether
the decline had any positive effect on those regions with
an excess mortality. In Texas, for example, where
approximately 11,000 new prostate cancer cases are
diagnosed every year,2 studies have found a decline in
prostate cancer mortality consistent with national statis-
tics in the late 1990s.6 Despite the general decline in
prostate cancer mortality, however, mortality disparities
continue to exist by race and region. Texas-specific can-
cer research identified several counties in the Dallas-Fort
Worth Metroplex region with an excess prostate cancer
mortality between 1990 and 1997.7 In terms of race,
between 1970 and 1994 in the Dallas-Fort Worth state
economic areas (SEAs), blacks had the highest rates of
prostate cancer mortality, and the Dallas-Fort Worth,
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Background: Prostate cancer mortality disparities exist
among racial/ethnic groups in the United States, yet few
studies have explored the spatiotemporal trend of the dis-
ease burden. To better understand mortality disparities by
geographic regions over time, the present study analyzed
the geographic variations of prostate cancer mortality by
three Texas racial/ethnic groups over a 22-year period.
Methods: The Spatial Scan Statistic developed by Kulldorff
et al was used. Excess mortality was detected using scan
windows of 50% and 90% of the study period and a spatial
cluster size of 50% of the population at risk. Time trend was
analyzed to examine the potential temporal effects of clus-
tering. Spatial queries were used to identify regions with mul-
tiple racial/ethnic groups having excess mortality.
Results: The most likely area of excess mortality for blacks
occurred in Dallas-Metroplex and upper east Texas areas
between 1990 and 1999; for Hispanics, in central Texas
between 1992 and 1996; and for non-Hispanic whites, in the
upper south and west to central Texas areas between 1990
and 1996. Excess mortality persisted among all racial/ethnic
groups in the identified counties. The second scan revealed
that three counties in west Texas presented an excess mor-
tality for Hispanics from 1980–2001. Many counties bore an
excess mortality burden for multiple groups. There is no time
trend decline in prostate cancer mortality for blacks and
non-Hispanic whites in Texas.
Conclusion: Disparities in prostate cancer mortality among
racial/ethnic groups existed in Texas. Central Texas counties
with excess mortality in multiple subgroups warrant further
investigation.
Key words: health disparities ■ prostate cancer ■ spatial
analysis ■ geographic information system
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Galveston and Potter/Randall SEAs had the highest rates
among whites.8 Abundant evidence relating to uneven
geographic distribution of prostate cancer mortality
underlines the importance of developing a more data-
driven and evidence-based surveillance approach to
monitoring potential health disparities, which renders an
opportunity for a closer look at the distribution of mor-
tality in diverse population groups over time. The pur-
pose of the present study was to determine whether the
declining prostate cancer mortality rates indicated
regional variations of potential excess prostate cancer
mortality over an extended period, and if so, at what level
of excess mortality in terms of temporal duration, rela-
tive risk and affected regions by county. The information
may be instrumental for planning for prostate cancer
intervention and health resource allocation to address the
regional health disparities.
METHODS
Location of the Study, Data Source
and Management
The study was conducted in the state of Texas, a state
with a diverse population, and included all counties in a
study period between 1980 and 2001. All data were sec-
ondary and included prostate-cancer specific deaths,
male population at risk and location. These data were
identified from the following reliable sources and saved
in separate files. The prostate-cancer-specific death cas-
es file was obtained from an open source (Texas Vital-
web),9 and included prostate cancer deaths (ICD-9 code
185 and ICD-10 code C61) by place of residence in 254
counties by four major racial/ethnic groups in Texas.
These were coded as categorical data (representing
blacks, Hispanics, non-Hispanic whites and others),
indicating the four subgroups in each of the 22 study
years. Each file contained an age-group categorical
variable with values labeled 1–16, representing ages
Table 1. Characteristics of male population under study and prostate cancer deaths, Texas, 1980–2001
Population Average Total Percent in All Cumulative Percentage Annual Adjusted*
Population Population (%) Deaths of Males Rate (Per 100,000)
All males 8,677,605 49.37 35,242 100 18.5
Black males 991,066 5.638 6,493 18.42 29.8
Hispanic males 2,305,930 13.12 3,450 9.79 6.8 
Non-Hispanic white males 5,187,210 29.51 25,219 71.56 22.1
Other males 193,397 1.10 80 0.23 1.9
* For overall rate (i.e., the population including all subgroups), both age and race/ethnicity are adjusted, while for race-specific rates
age is adjusted.
Figure 1. Excess mortality of prostate cancer among Anglo males in Texas counties, 1980–2001
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ranging from “0–4” to “≥75,” grouped by five-year
intervals. A total of 89,408 records for each of the case
files reflected the number of prostate cancer deaths per
population group among 16 age groups in 254 counties
over the 22-year study period. The second file, named
“population file,” included populations at risk in the
study period; i.e., the male population in each county by
all study years with the respective race and age group
information corresponding to the deaths file. Centennial
population data, including race/ethnicity and age group,
were obtained from the year 1990/2000 Census Ameri-
can FactFinder Website originated by the U.S. Census
Bureau.10 The other 20 years of population data were
obtained from population estimates made available
through the Texas State Data Center and the Center of
Vital Statistics of Texas Department of Health.11 The
“population file” contained a total of 357,632 records,
representing four racial/ethnic groups by 16 age groups
in 254 counties for the 22-year study period. In this file,
age group variables were also coded as categorical data
to enable adjustments for age in the Texas population.
The third file, the “geographic file,” also obtained from
the U.S. Census Bureau,12 contained latitude and longi-
tude information of Texas county centroids as a proxy
indicating the locality of each county. 
Data Analysis
First, we evaluated the geographic excess of prostate
cancer mortality in the selected population groups at the
county level and characterized the excess burden by
spatiotemporal variations represented by their respec-
tive relative risk, duration and p values indicating the
homogeneity of prostate cancer mortality distribution.
Second, we tested the potential persistence of excess
deaths into the present decade. The resulting temporal
patterns were compared with previous studies for a
trend of declining mortality. Third, we performed spatial
queries to identify the excess mortality affecting multi-
ple subgroups over time. Based on the results of these
analyses, we identified the racial/ethnic group(s) and
the region(s) that might have been affected by a persist-
ent excess mortality over time. 
This study used the Spatial Scan Statistic developed
by Kulldorff et al.13-14 to detect potential excess mortality
and adjust for covariates. The particular value of the
spatiotemporal method is that it can detect “geographic”
or “temporal” (or both) excess mortality that spanned
only a limited portion of the full study period, or a
selected time period within the study period as defined
by the investigators. The method pinpoints the geo-
Table 2. Relative risk of prostate cancer according
to age group and race in Texas, 1980–2001
Relative Risk 95% CI
Age Group
20–39 0.05 (0.05, 0.06)
40–59 0.48 (0.47, 0.49)
60–69 referent –
≥70 1.49 (1.46, 1.53)
Race
Black 1.28 (1.25, 1.32)
Hispanic 0.67 (0.65, 0.69)
White referent –
Other 0.39 (0.35, 0.44)
Figure 2. Excess mortality of prostate cancer among Anglo males in Texas counties, 1980–2001 
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graphic location, temporal duration, relative risk and
statistical significance of the identified clusters. The
method has been used elsewhere in similar studies of
other types of cancer15,16 and of accidental poisoning
Table 3. Texas counties detected with excess prostate cancer mortality among non-Hispanic whites,
blacks and Hispanics, 1980–2001
Population Years Number Annual Age-Adjusted P Relative Number of
Subgroups (Duration) of Deaths Rate/100,000 Value Risk Counties
Spatio-Temporal Excess Mortality
Primary cluster for non-Hispanic white male population
(50% and 90% study period, and 50% population at risk)
1990–1996 (7) 4,420 26.2 0.001 1.22 107
Primary cluster for black male population
(50% and 90% study period, and 50% population at risk)
1990–1999 (10) 1,783 38.3 0.001 1.39 79
Primary cluster for Hispanic male population
(50% of study period, and 50% population at risk)
1991–2001 (11) 1228 9.9 0.001 1.19 146
Secondary cluster for Hispanic male population
(50% study period and 50% population at risk)
1992–1996 (5) 252 9.7 0.003 1.45 10
Primary cluster for Hispanic male population
(90% of study period, and 50% population at risk)
1980–2001 (22) 523 9.8 0.001 1.52 3
Primary cluster for other male population
(50% of study period, and 50% population at risk)
1989–1999 (11) 39 3.4 0.3 1.8 53
* Excess mortality is defined as up to 50% of study population, with temporal persistence of up to 50% or 90% of the study years. All
included spatial only adjusting for time non-parametrically.
Figure 3. Excess mortality of prostate cancer among black males in Texas Counties, 1980–2001 
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mortality disparities.17 A “cluster” refers to a geographi-
cal area that during a specific timeframe has experi-
enced a disproportionate excess in mortality when com-
pared to surrounding areas.18 A cluster can be either an
increase or decrease in mortality, but this study only
looked at increased mortality. This study used “clusters”
and “excess mortality” interchangeably, with both terms
referring to the statistical context of both spatial and
temporal dimensions of excess mortality.
The key test of the spatial scan statistic proposes that
by meeting the assumptions of a set of statistical mod-
els, the unusual increase (or reduction) of mortality in
specific spatial and temporal windows (adjusted for risk






















All White Black Hispanic
Exhibit 1. Age-adjusted prostate cancer mortality rates of Texas between 1980 and 2001 (standardized to
2000 U.S. population)
Figure 4. Excess mortality of prostate cancer among black males in Texas counties, 1980–2001
Decrease in mortality rates observed after 1998 may be reflective of the change in ICD 9/10 coding conventions. There is no
significantly increasing or decreasing linear trend (RR=1.003, 95% confidence interval: 1.001, 1.004)
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mortality rates, duration of excess, relative risk and sta-
tistical significance. The method factors in the uneven
geographical population density and bases the analyses
on the total number of observed prostate cancer deaths.
In an analysis of relatively rare cases/deaths such as
prostate cancer, the Poisson model can be used for esti-
mating the probability distribution when the number of
cases is small compared to the population at risk. The
null hypothesis of the Poisson model provides that,
when there are no confounding factors, the expected
death counts in each county are proportional to its popu-
lation size (or person-years) in that area. The alternative
hypothesis is that deaths are not proportionately and
randomly distributed.
In the present study, for each location and size of the
scanned space and time, the null hypothesis is that the
Figure 5. Excess mortality of prostate cancer among Hispanic males in Texas counties, 1980–2001 
Figure 6. Excess mortality of prostate cancer among Hispanic males in Texas counties, 1980–2001
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prostate cancer death rates in a scanned region are ran-
domly distributed, meaning they do not exceed those
outside the scanned region. The alternative hypothesis is
that there are elevated cancer mortality rates within the
scanned space and time as compared to outside areas,
and that deaths are distributed heterogeneously in the
entire study area, meaning that the deaths in the putative
cluster of space and time exceeded those outside of the
cluster.
Calculations were performed using SaTScan™ version
6.0.18 Analytic approaches have been described elsewhere
by the authors17,19 and will only be briefly summarized
here. The Poisson model was used to calculate expected
deaths in each county. The space–time retrospective
analysis was conducted without prior assumptions of the
size, location or duration of excess mortality. First, the
default scanning setting of a maximum spatial cluster size
at 50% of the population at risk, and 50% of the study
period (i.e., 11 years) was set. The “50% of population at
risk” parameter was recommended by Kulldorff 18 as an
optimal value setting that maximizes the effect of poten-
tial cluster detection. This would mean that a cluster
would comprise at most 50% of the population at risk.
The “study period” option was set at 50% and again at
90% for comparison. Secondly, the study further tested
whether excess cases in any region may persist through
the year 2000, by holding constant the 50% maximum
spatial cluster but scanning for up to 90% of the study
period of 19 years. Both analyses include spatial only
with the adjustments of time trend nonparametrically to
offset the effect of temporal trend. As implemented in
SaTScan, the method employed for adjusting rate of
age/race is indirect adjustment.
Appendix A describes the stepwise progression of
the calculation. The output files, including cluster loca-
tions, the respective relative risk and the results of test
statistic, were saved in database (.dbf format) files for
exporting to geographic information systems (GIS) for
Appendix A. Descriptions of the stepwise progression of data processing
After downloading the cases/deaths, population and county centroids files, the VBA program:
1. Imports, aligns and exports data tables to SaTScan-compatible format: The program first creates three
folders to be used as working directories and to save results of SaTScan analysis. They are “maps,”
“results” and “folders named by gender and race/ethnicity.” It then imports all downloaded
case/deaths files to the VBA, aligning and extracting data to a SaTScan-compatible format with each
data table, including the fields of County ID and case/death numbers stratified by years, age, gender
and race/ethnicity. Another data table with the same fields (but substituting cases/deaths with
population numbers) is also prepared.
2. Deletes tables: After creating the cases and population files, all the downloaded files that were
imported for this purpose in step 1 are then deleted. This step is necessary in order to reduce the size of
the VBA and maximize the speed of ensuing steps. Once the files are deleted, the program invokes
SaTScan scripts in the “scripts” folder.
3. Runs SaTScan: By invoking SaTScan scripts, the program opens four windows to perform four SaTScan
concurrent sessions. These sessions include four windows of analysis, including two for all populations
combined and two for non-Hispanic whites, each with windows of 50% spatial cluster and 50% temporal
cluster, and 50% spatial and 90% temporal cluster, respectively.
4. Pauses: The program then pauses for 4,200 seconds (70 minutes) for SaTScan to process data. For this
study, there were 725,000 records entered for processing.
5. Renames all GIS files to be Access compatible: After the SaTScan process is complete, the resultant
GIS files are then renamed to MS-DOS compliant format of [filename].[extension] (for example, the
default “all.gis.dbf” of the SaTScan output file was renamed “to all.dbf”).
6. Imports GIS files to tables: To tabulate the results of cluster information, the program “imports” and
“unions” (both SQL commands) all GIS files as one consolidated file and presents it in a report format.
7. Exports GIS files to map: The VBA then exports the aligned GIS result files to spatially join with Texas
county boundary files and present the location of clusters in choropleth maps. It then invokes an ArcGIS
map document of four data layers (representing “all population” “non-Hispanic white”, “black” and
“Hispanic” population by 50% population, 50% study year, and 50% population, 90% study year
respectively) that were preformatted. For this study, the entire analysis took 70 minutes to run on a
standard PC (1.5 MHz Pentium IV). The VBA outputs and prints all SaTScan result files upon the
completion of the scan analysis.
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further analysis. Data were stored in a Microsoft SQL
Server version 7.0, and Visual Basic Application (VBA)
code was developed by the first author to automate data
manipulation, interface with SaTScan and output the
results to a GIS. The automated process, from data
input, scanning, to output, took a total of 70 minutes of
computer time.
RESULTS
The study analyzed 35,242 prostate cancer deaths
among an average population of 8,677,605 males in
Texas for the 22-year time period. The age- and race-
adjusted annual prostate cancer mortality rate was
18.5/100,000 men/year. Table 1 summarizes the charac-
teristics of the study population and their subgroups.
Blacks had the highest annual age-adjusted rate (29.8
Figure 7. Excess mortality of prostate cancer among “the other” males in Texas counties, 1980–2001 
Figure 8. Excess mortality of prostate cancer among  "the other" males in Texas counties, 1980–2001 
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per 100,000). Exhibit 1 illustrates subgroup-specific
rates over the study year and indicates that the rates in
Texas counties were relatively stable over the 22-year
study period. The risk of prostate cancer according to
age group and race are presented in Table 2. The great-
est risk was observed among black males and among
people aged >70 years. However, the pattern of risk
according to age group did not vary according to
race/ethnicity.
With the adjustments of age and stratified by race, and
with a scan window of a maximum of 50% of the study
period (11 years) and 50% of the population at risk (4.4
million males in Texas), the first spatiotemporal analysis
detected five regions of likely excess mortality in three
racial/ethnic groups having statistical significance in
terms of both spatial and temporal excess. Standardized
mortality ratios ranged from 1.22–1.49. Figures 1, 3, 5
and 7 present these areas with likely excess mortality
from the first analysis by each race, including: 1) the
most likely (primary) cluster among each race, and 2)
those clusters of statistical significance.
Table 3 summarizes the results of analysis for non-His-
panic whites, blacks and Hispanics by potential excess mor-
tality, duration of occurrence, observed deaths, counties and
relative risk information in each cluster of excess mortality.
For the non-Hispanic white population, the most likely area
of excess mortality with a relative risk (RR) of 1.22
(p=0.001) occurred between 1990 and 1996 and included
107 counties ranging from upper south Texas, west to cen-
tral Texas. For blacks, the most likely area of excess mortali-
ty (RR=1.39, p=0.01) occurred between 1990 and 1999 in
the Dallas–Fort Worth Metroplex and upper east Texas.
These included 79 counties with 10 years of persistence.
For Hispanics, the most likely area of excess mortality
(RR=1.19, p=0.001) occurred between 1991 and 2001 from
the upper Rio Grande, west, high plains, northwest to cen-
tral Texas, including 146 counties; and a secondary excess
mortality cluster was found in 10 upper south counties
(RR=1.45, p=0.003) between 1992 and 1996. For the “oth-
er” racial/ethnic/ethnic population, the most likely cluster
(RR=1.80, p=0.31) was found in the counties of the Gulf
Coast and Central Texas. This cluster included 53 counties
and was not statistically significant. In the first scan trial,
suspected clusters for Hispanics and “other” persisted for
11 years, and the cluster for blacks persisted for 10 years,
which was around the maximum temporal size (50% of the
study years) set for this analysis. To detect whether these or
other clusters might have persisted across most of the study
period, a second scan analysis was performed with 90% of
the study period as the maximum temporal size (i.e., 19
years), and with a 50% population at risk setting as previ-
ously adopted. Figures 2, 4, 6 and 8 present the results of
likely clusters in this second scan. The results indicate that
the temporal excess level and the counties of the primary
cluster among non-Hispanic whites and blacks did not
change. However for Hispanics, the most likely cluster
(RR=1.52, p= 0.001) narrowed down to three southwest
counties (El Paso, Hudspeth and Culberson) between 1980
and 2001. For the “other” racial/ethnic group, the most like-
ly cluster (RR=1.68, p=0.30) was detected with a temporal
persistence of 13 years, between 1989 and 2001. This was
not statistically significant.
Figure 9. Excess mortality of prostate cancer among  multiple racial groups in Texas counties, 1980–2001
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To detect the cluster regions that affected multiple
racial/ethnic groups, we further conducted spatial
queries on those counties for which clusters were detect-
ed for racial/ethnic group(s). This spatiotemporal analy-
sis found that many counties bore a higher mortality
burden in multiple races. Figure 9 is a color-coded map
that presents overlaid cluster layers for each race.
Among them, excess prostate cancer mortality was
found in 11 counties in central and the Dallas–Fort
Worth Metroplex areas among all four racial/ethnic
groups; 25 counties in central-to-Gulf Coast Texas were
found to have an excess among non-Hispanic whites
and blacks; 62 counties in west, central and upper south
Texas among non-Hispanic whites and Hispanics; and
22 counties in northwest and the Dallas–Fort Worth
Metroplex among blacks and Hispanics.
DISCUSSION
This study identified spatiotemporal trends of excess
prostate cancer mortality in Texas that mirrored national
and local trends, while revealing new information that
warrants further investigation. First, the results indicat-
ed that between 1981 and 2001, five geographic regions
experienced excess prostate cancer mortality rates that
were statistically significant. The geographic areas iden-
tified with excess mortality generally parallel the analy-
sis of 1970–1994 data by the National Institutes of
Health8 and 1990–1997 data by Zhan,7 and confirm
most of the counties that were previously suspected of
having elevated prostate cancer mortality. Furthermore,
the present study additionally identified the west-to-
central Texas region as having excess mortality from
prostate cancer in the Hispanic population, which per-
sisted for >11 years. This had not been previously
reported. The statistically significant relative risks of
these clusters were at levels of 1.19–1.49 between 1981
and 2001, which are the highest relative risks with the
longest temporal persistence detected among any of the
racial/ethnic groups. The trend of excess mortality
seems to persist into the current decade for Hispanics in
the detected region. The findings that no “hot-spots”
(i.e., RR >2) excess prostate cancer mortality were
found paralleled the results of our previous spatial
analysis of breast cancer19 and colorectal cancer20 clus-
ters in Texas. Third, as a caveat of Exhibit 1, there may
have been points in time where the trend increased or
decreased significantly (i.e., among blacks), but, over-
all, we did not observe this trend. Fourth, the suspected
cluster of excess mortality among blacks in upper east
Texas persisted for 10 years but decreased after 1999
(i.e., the mortality rate declined in that year). The non-
Hispanic white cluster (with a RR of 1.22) was only
present for 7 years, vanishing after 1996. The declining
deaths for non-Hispanic whites (starting in 1996) and
blacks (starting in 1999) observed by this study are gen-
erally consistent with national and state-level stud-
ies,6,15,21 although temporal analysis (Exhibit 1) suggest-
ed that there is no temporal trend of the decrease. Based
on these findings, it appears that the Hispanic popula-
tion had the highest burden of prostate cancer mortality
during the study period in the identified regions, as evi-
denced by both spatial concentration and temporal per-
sistence. Despite Hispanics having the lowest age-
adjusted annual rate of prostate cancer, they
nevertheless were strongly affected in terms of cluster-
ing in space and time. More studies are needed to find
out why, as the clusters could provide a clue to prostate
cancer etiology.
The clustering of prostate cancer mortality detected
in this study could reflect underlying disparities in the
causation of this disease, and/or delay in diagnosis and
treatment. The analysis controls for age by race; thus,
higher prostate cancer mortality rates cannot be
explained by a higher proportion of older men in a geo-
graphic area per se. However, since age is a risk factor
for this disease, the relative importance of mortality
from competing causes of death could play a significant
role in prostate cancer mortality. Moreover, mortality
rates for various diseases differ by race/ethnicity.22 This
may be especially true in older men where conditions
such as cardiovascular disease, stroke and diabetes more
aggressively take their toll, while prostate cancer is
often a slowly progressing disease. Highly differential
causes of death have been found between racial/ethnic
groups in one study of Texas prostate cancer registry
patients [see Miller, JA Prostate Cancer in Texas:
Addressing Racial/Ethnic and Ethnic Disparities.
(unpublished dissertation). University of Texas School
of Public Health, 2004. http://digitalcommons.library.
tmc.edu/dissertations/AAI3143613/]. Additionally, an
unusually low number of males in an area could intro-
duce statistical instability in mortality rates from other
diseases. This study did not consider the age of incident
prostate cancer or survival times after diagnosis.
The cohesive, persistent and statistically significant
nature of the clusters detected in this study would sug-
gest that there are underlying contributing factors to
prostate cancer mortality that might not exist outside the
clusters and that may be addressed through public
health research and policy. Racial/ethnic disparities
continue to call for attention as one of the top-10 lead-
ing health priorities identified by the Healthy People
2010 National Health Objectives.23 Socioeconomic fac-
tors, social environment and access to clinical preven-
tive services contribute to racial/ethnic disparities in
disease mortality. In areas of high immigration, such as
Texas, lack of familiarity with the U.S. healthcare sys-
tem, different cultural attitudes about the use of tradi-
tional and conventional medicine and lack of familiarity
with English can pose barriers to accessing appropriate
healthcare and receiving prostate cancer screening. 
The identification of clusters of prostate cancer
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excess mortality over time may prove beneficial for
health policy and planning. For instance, Texas has yet
to meet the Healthy People 2010 objective of reducing
prostate cancer death rates to below 28.7 per 100,000
men.23 By looking ahead into the current decade and
working to reach this objective, the detection of excess
prostate cancer mortality and identification of achiev-
able interventions may assist in reaching the established
goal. The spatiotemporal analysis presented here identi-
fied the regions with a concentrated, persistent excess
burden of prostate cancer mortality among various
racial/ethnic groups, particularly in those 11 counties
that are bearing an excess mortality burden in all four
racial/ethnic groups. In addition, the second scan, with a
maximum of 90% of the study period, detected a possi-
ble 19-year persistence of excess prostate cancer mor-
tality in Hispanics in the upper Rio Grande area of
Texas. This finding, in combination with the results of
the 50% temporal persistence, suggests that the “cluster
trend” may be ongoing and has persisted into the current
decade. The trend may be due to a lack of access to
prostate cancer screening among uninsured Hispanics
living in the detected region. This area of “active”
excess mortality burden warrants further investigation
and policy intervention.
The likely cluster of excess mortality among Hispan-
ics in those western counties should also be considered in
the context of migration patterns in this area of Texas.
Cross-border migration is common, and rate denomina-
tors taken from census estimates may not reflect undocu-
mented migration and actual population. Using accurate
mortality counts while underestimating the denominator
population at risk could inflate mortality rates.
Two technical notes warrant elaboration in the present
study. First, although the study focused primarily on sta-
tistically significant excess mortality, it by no means sug-
gests that those regions of nonstatistical significance of
excess mortality were less important. To determine statis-
tical significance at the 0.05 or 0.01 level, outcome meas-
ures had to satisfy the Poisson distribution model, and all
predictors/covariates in this study, including space, time,
age and race, would have fitted into the model simultane-
ously and produced a large log-likelihood ratio in the spa-
tial-temporal analysis. The p value denoting significance
is only an indicator suggesting that the level of excess
mortality calls for further investigation.
Lastly, this study was completed by using the soft-
ware ArcView from Environmental Science Research
Institute (ESRI) and the free SaTScan. The mapping
tasks implemented in ArcViews can be completed using
the EpiMap component of EpiInfo, freely available from
the Centers for Disease Control and Prevention. The
free system might benefit medically underserved
regions in the US, as well as developing countries where
limited resources are available yet have pressing needs
for health surveillance.
LIMITATIONS
Several research issues warrant further discussion.
First, the modest relative risks occurring over a large
area of contiguous counties do not necessarily indicate
“clusters” of conventional epidemic intensity. Prostate
cancer may have a substantial developmental period,
and has causes and risk factors that are not fully under-
stood and which may operate over various time scales.
The mortality captured here is only an endpoint in that
process. Further epidemiologic study and effective poli-
cy interventions to address this mortality might ideally
be applied outside the windows of space or time consid-
ered here. Nevertheless, this study offered baseline
descriptions of persistently elevated prostate cancer
deaths in Texas, which may serve as a point of departure
for further investigation and planning of health resource
allocations.
Second, the study identified seven counties (e.g.,
Loving and King counties) averaging <10 prostate can-
cer deaths and <900 residents in the study period. Rates
based on small numbers of events and population tend
to be unpredictable and often inflated. Readers are
advised to use caution when trying to interpret health
outcomes, including the excess disease mortality, in
these sparsely populated counties.
Third, this study considered three major population
subgroups of Texas, in addition to the “other” group.
Most state-level data collection and surveillance sys-
tems include two (white/blacks or African American) or
three (non-Hispanic white, black or African American,
and Hispanic) population groups. However, this is not
consistent with the U.S. Office of Management and
Budgeting Statistical Directive15,24 which provides guid-
ance for the collection and reporting of health data by
six races (including American Indian or Alaska Native,
Asian, black or African American, Native Hawaiian,
Pacific Islander and white) and two ethnicities (Hispan-
ic or Latino versus non-Hispanic or Latino). Misclassi-
fication of race/ethnicity may account for some persons
being categorized as “other,” in which case the mortality
rates for correctly categorized race/ethnicities may be
over- or underestimated, although how this affects the
detection of clusters (i.e., relative rates between
racial/ethnic groups) remains unclear. Misclassification
may come from two sources: census and cancer registry. 
CONCLUSION
Between 1980 and 2001, five regions of potential
excess prostate cancer mortality were detected in Texas
counties among non-Hispanic white and Hispanic
groups with statistical significance. Among all
racial/ethnic groups, Hispanics in three counties of the
upper Rio Grande portion of Texas had the highest bur-
den of this disease mortality as evidenced by spatial
concentration and temporal persistence. Researchers
and health authorities may wish to direct particular
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attention to the excess mortality among Hispanics in
these three counties that have extended for >19 years
and may have persisted into the current decade. In addi-
tion, 11 counties in central Texas that had multiple races
affected by excess mortality over time warrant further
epidemiologic investigation and policy intervention.
Future spatiotemporal studies may control for other risk
factors, as explanatory variables would explain more of
the variation seen in the data, resulting in smaller p val-
ues for clusters.
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